McLaughlin T - Search Results

1

Safety, efficacy and pharmacokinetics of repeat subcutaneous dosing of avexitide (exendin 9-39) for treatment of post-bariatric hypoglycaemia.

Tan M, Lamendola C, Luong R, McLaughlin T, Craig C. Tan M, et al. Among authors: mclaughlin t. Diabetes Obes Metab. 2020 Aug;22(8):1406-1416. doi: 10.1111/dom.14048. Epub 2020 May 4. Diabetes Obes Metab. 2020. PMID: 32250530

2

Efficacy and pharmacokinetics of subcutaneous exendin (9-39) in patients with post-bariatric hypoglycaemia.

Craig CM, Liu LF, Nguyen T, Price C, Bingham J, McLaughlin TL. Craig CM, et al. Among authors: mclaughlin tl. Diabetes Obes Metab. 2018 Feb;20(2):352-361. doi: 10.1111/dom.13078. Epub 2017 Sep 24. Diabetes Obes Metab. 2018. PMID: 28776922 Clinical Trial.

3

PREVENT: A Randomized, Placebo-controlled Crossover Trial of Avexitide for Treatment of Postbariatric Hypoglycemia.

Craig CM, Lawler HM, Lee CJE, Tan M, Davis DB, Tong J, Glodowski M, Rogowitz E, Karaman R, McLaughlin TL, Porter L. Craig CM, et al. J Clin Endocrinol Metab. 2021 Jul 13;106(8):e3235-e3248. doi: 10.1210/clinem/dgab103. J Clin Endocrinol Metab. 2021. PMID: 33616643 Free PMC article. Clinical Trial.

4

Defining clinically important hypoglycemia in patients with postbariatric hypoglycemia.

Craig CM, McLaughlin TL. Craig CM, et al. Surg Obes Relat Dis. 2021 Nov;17(11):1865-1872. doi: 10.1016/j.soard.2021.06.013. Epub 2021 Jun 29. Surg Obes Relat Dis. 2021. PMID: 34275761

5

Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia.

Craig CM, Liu LF, Deacon CF, Holst JJ, McLaughlin TL. Craig CM, et al. Diabetologia. 2017 Mar;60(3):531-540. doi: 10.1007/s00125-016-4179-x. Epub 2016 Dec 14. Diabetologia. 2017. PMID: 27975209 Free PMC article. Clinical Trial.

6

Plasma FGF-19 Levels are Increased in Patients with Post-Bariatric Hypoglycemia.

Mulla CM, Goldfine AB, Dreyfuss JM, Houten S, Pan H, Pober DM, Wewer Albrechtsen NJ, Svane MS, Schmidt JB, Holst JJ, Craig CM, McLaughlin TL, Patti ME. Mulla CM, et al. Obes Surg. 2019 Jul;29(7):2092-2099. doi: 10.1007/s11695-019-03845-0. Obes Surg. 2019. PMID: 30976983 Free PMC article.

7

Lipoprotein risk factors for cardiovascular disease in patients with type 2 diabetes mellitus treated with oral antihyperglycaemic agents.

Chu JW, Abbasi F, McLaughlin TL, Lamendola C, Schaaf P, Carlson TH, Leary ET, Reaven GM. Chu JW, et al. Among authors: mclaughlin tl. Diabetes Obes Metab. 2003 Sep;5(5):333-7. doi: 10.1046/j.1463-1326.2003.00284.x. Diabetes Obes Metab. 2003. PMID: 12940871

8

Metabolic markers, regional adiposity, and adipose cell size: relationship to insulin resistance in African-American as compared with Caucasian women.

Allister-Price C, Craig CM, Spielman D, Cushman SS, McLaughlin TL. Allister-Price C, et al. Int J Obes (Lond). 2019 Jun;43(6):1164-1173. doi: 10.1038/s41366-018-0191-1. Epub 2018 Aug 20. Int J Obes (Lond). 2019. PMID: 30127463 Free PMC article.

9

Improvement in insulin sensitivity followed by ovulation and pregnancy in a woman with polycystic ovary syndrome who was treated with rosiglitazone.

Cataldo NA, Abbasi F, McLaughlin TL, Lamendola C, Reaven GM. Cataldo NA, et al. Among authors: mclaughlin tl. Fertil Steril. 2001 Nov;76(5):1057-9. doi: 10.1016/s0015-0282(01)02843-6. Fertil Steril. 2001. PMID: 11704136 Free article.

10

Multiple lipoprotein abnormalities associated with insulin resistance in healthy volunteers are identified by the vertical auto profile-II methodology.

Chu JW, Abbasi F, Kulkarni KR, Lamendola C, McLaughlin TL, Scalisi JN, Reaven GM. Chu JW, et al. Clin Chem. 2003 Jun;49(6 Pt 1):1014-7. doi: 10.1373/49.6.1014. Clin Chem. 2003. PMID: 12766017 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

508 results

Search Page

Filters